Sharecare, Inc. (NASDAQ:SHCR) Short Interest Update

Sharecare, Inc. (NASDAQ:SHCR - Get Free Report) was the recipient of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 2,960,000 shares, a decline of 20.9% from the July 31st total of 3,740,000 shares. Currently, 1.0% of the shares of the company are sold short. Based on an average daily volume of 4,190,000 shares, the short-interest ratio is presently 0.7 days.

Sharecare Stock Performance

NASDAQ:SHCR remained flat at $1.39 during trading hours on Thursday. The company's stock had a trading volume of 1,884,889 shares, compared to its average volume of 2,657,549. The business's 50-day simple moving average is $1.38 and its two-hundred day simple moving average is $1.03. Sharecare has a 52 week low of $0.48 and a 52 week high of $1.40. The firm has a market cap of $503.75 million, a P/E ratio of -3.76 and a beta of 0.50.

Analyst Upgrades and Downgrades

Several analysts have commented on SHCR shares. Canaccord Genuity Group lowered Sharecare from a "strong-buy" rating to a "hold" rating in a report on Friday, June 21st. Morgan Stanley lifted their price target on shares of Sharecare from $1.00 to $1.43 and gave the company an "equal weight" rating in a research note on Monday, June 24th. Finally, Canaccord Genuity Group restated a "hold" rating and set a $1.43 price objective (down from $2.00) on shares of Sharecare in a research report on Friday, June 21st.

Insider Buying and Selling

In other Sharecare news, insider Jeffrey T. Arnold sold 177,085 shares of Sharecare stock in a transaction on Friday, August 16th. The shares were sold at an average price of $1.38, for a total value of $244,377.30. Following the completion of the transaction, the insider now owns 4,790,406 shares of the company's stock, valued at $6,610,760.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 29.27% of the stock is currently owned by insiders.

Institutional Trading of Sharecare

Large investors have recently made changes to their positions in the company. Millennium Management LLC boosted its stake in Sharecare by 12,938.8% during the 2nd quarter. Millennium Management LLC now owns 6,092,772 shares of the company's stock worth $8,225,000 after purchasing an additional 6,046,044 shares during the last quarter. Private Management Group Inc. lifted its stake in shares of Sharecare by 127.4% in the first quarter. Private Management Group Inc. now owns 9,284,572 shares of the company's stock worth $7,126,000 after buying an additional 5,201,296 shares in the last quarter. Squarepoint Ops LLC boosted its position in Sharecare by 7,841.4% during the second quarter. Squarepoint Ops LLC now owns 2,511,468 shares of the company's stock worth $3,390,000 after acquiring an additional 2,479,843 shares during the last quarter. Gabelli Funds LLC purchased a new stake in Sharecare during the 2nd quarter valued at about $892,000. Finally, Sagefield Capital LP acquired a new stake in Sharecare in the 2nd quarter valued at about $814,000. 35.08% of the stock is currently owned by hedge funds and other institutional investors.

About Sharecare

Sharecare, Inc operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.